Initial treatment of myxedema coma using oral levothyroxine: a case report from Tanzania.
Journal
Endocrinology, diabetes & metabolism case reports
ISSN: 2052-0573
Titre abrégé: Endocrinol Diabetes Metab Case Rep
Pays: England
ID NLM: 101618943
Informations de publication
Date de publication:
01 Apr 2022
01 Apr 2022
Historique:
received:
03
03
2022
accepted:
10
03
2022
pubmed:
26
4
2022
medline:
26
4
2022
entrez:
25
4
2022
Statut:
aheadofprint
Résumé
Myxedema coma is a severe complication of hypothyroidism, commonly affecting women over 60 years of age, causing slow, progressive multi-organ dysfunction, and mental deterioration. Due to improved diagnostics and treatment of hypothyroidism, myxedema coma has become uncommon. However, it is hardly reported in resource-limited settings. We present an elderly female with a history of total thyroidectomy due to multi-nodular goiter. She presented with features of heart failure, excessive weight gain, and cold sensation. Although the patient was on levothyroxine replacement therapy, her laboratory tests were suggestive of overt primary hypothyroidism. During the course of her hospitalization, she developed subcutaneous bleeding with frank hematuria. This led to an altered mental state and hypotension that were suggestive of myxedema coma. Stroke and pulmonary embolism were ruled out as potential differential diagnoses of her current state. She was treated with a high dose of oral levothyroxine followed by 150 μg of oral levothyroxine daily, which resulted in a favorable outcome despite being a fatal emergency. She was also treated with intravenous hydrocortisone and furosemide. Oral thyroid hormone replacement may be an effective option in those resource-limited settings where intravenous thyroid hormone replacement is not available. However, early diagnosis and treatment with an adequate dose of thyroid hormones are crucial to achieve a favorable outcome. Myxedema coma is an uncommon complication of hypothyroidism with a fatal outcome. The diagnosis of myxedema coma is based on clinical suspicion, especially in patients with hypothyroidism and in the presence of precipitating factors. Although diagnostic and scoring criteria based on clinical, laboratory, and imaging features have been proposed, no consensus has been reached. This article shows an alternative treatment option for myxedema coma using oral levothyroxine, which led to a favorable outcome.
Identifiants
pubmed: 35466083
doi: 10.1530/EDM-21-0197
pii: 21-0197
pmc: PMC9066563
doi:
pii:
Types de publication
Journal Article
Langues
eng
Références
Eur J Endocrinol. 2017 Jan;176(1):R15-R20
pubmed: 27484454
Ghana Med J. 2017 Mar;51(1):39-42
pubmed: 28959072
Eur Thyroid J. 2021 Mar;10(1):52-58
pubmed: 33777819
J Epidemiol. 2017 Mar;27(3):117-122
pubmed: 28142035
J Thyroid Res. 2011;2011:493462
pubmed: 21941682
Clin Appl Thromb Hemost. 2001 Apr;7(2):113-5
pubmed: 11292187
Thyroid. 2014 Dec;24(12):1670-751
pubmed: 25266247
Thyroid. 1999 Dec;9(12):1167-74
pubmed: 10646654